BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 21, 2022
View Archived Issues
p62 is required to eliminate pathological oligomeric tau species in a mouse model of tauopathy
Read More
Dapl1 identified as novel target for cancer immunotherapy
Read More
Incyte patents new JAK2 inhibitors
Read More
Korea Institute of Science and Technology divulges TGF-beta inhibitors
Read More
Wuhan Yuxiang Pharmaceutical Technology identifies SOS1/KRAS interaction inhibitors
Read More
Janssen Pharmaceutica synthesizes new CDK7 inhibitors
Read More
Hong Kong Baptist University divulges new antiviral compounds
Read More
Biallelic variants in RASGRP2 gene tied to bleeding diathesis
Read More
Health Canada clears QBKPN to enter clinic to restore innate immunity in elderly
Qu Biologics has received clearance from Health Canada to proceed with a randomized, placebo-controlled trial of QBKPN, a first-in-class innate immune modulator that enhances lung immunity, in the elderly.
Read More
SMIM1 gene loss-of-function variant found to increase the risk of stroke
Read More
Identification of novel vanin-1 inhibitors
Read More
SARS-CoV-2 infection of neurons; no ACE2 required
Read More